Vaxigriptetra

Vaxigriptetra is a quadrivalent influenza vaccine designed to protect against four flu strains, including B/Phuket/3073/2013-like and B/Michigan/01/2021 viruses. This seasonal vaccine helps reduce flu risk by stimulating immunity. Suitable for adults and children, it is administered annually. Ideal for flu prevention during peak seasons.

Vaxigriptetra is used to help prevent influenza, commonly known as the flu, caused by four specific virus strains. It is designed for seasonal vaccination to reduce the risk of flu-related illness. The vaccine works by prompting the immune system to produce antibodies against targeted flu viruses. It is recommended for individuals seeking seasonal flu protection.

After vaccination, some individuals may experience mild effects such as soreness at the injection site or low-grade fever. These reactions typically resolve within a few days. The vaccine itself does not cause the flu but may produce temporary discomfort as the body builds immunity.

Vaxigriptetra should be handled with care, stored at recommended temperatures, and administered by a healthcare professional. Individuals with severe allergies to vaccine components, including eggs, should consult a doctor before use. Post-vaccination monitoring is advised for any unusual reactions.

Limited data exists on interactions with other vaccines or medications. However, simultaneous administration with other vaccines may require separate injection sites. Always inform your healthcare provider about any medications or recent vaccinations to ensure safe administration.